Smith Mark Douglas Insider Trading Activity (PHR)

Summary

Updated Jul 16, 2026

Smith Mark Douglas has filed 3 SEC Form 4 filings across 3 companies in the last 90 days — selling. Lifetime open-market sales: $470K.

Role	Director
Notability	20/100

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-06-26	PHR	Phreesia, Inc.	A — Grant or award	19.3K	$9.59	$185K
2026-06-17	JAZZ	Jazz Pharmaceuticals plc	S — Open-market sale	1.2K	$230.55	$267K
2025-08-07	JAZZ	Jazz Pharmaceuticals plc	F — Tax withholding / forfeiture	1.8K	$111.25	$201K
2025-08-07	JAZZ	Jazz Pharmaceuticals plc	A — Grant or award	3.5K	$0.00
2025-07-02	PHR	Phreesia, Inc.	S — Open-market sale	7.0K	$29.00	$203K
2025-07-02	PHR	Phreesia, Inc.	M — Option exercise	7.0K	$4.71	$33K

Companies — Last 90 Days

Phreesia, Inc. (PHR) — 1 filings, last 2026-06-26
Jazz Pharmaceuticals plc (JAZZ) — 1 filings, last 2026-06-17
Teladoc Health, Inc. (TDOC) — 1 filings, last 2026-05-21

Frequently Asked Questions

Who is Smith Mark Douglas?

Smith Mark Douglas is a corporate insider — currently tracked as Director of Phreesia, Inc. (PHR). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Smith Mark Douglas submitted recently?

3 primary Form 4 filings in the last 90 days, covering 3 companies.

Has Smith Mark Douglas been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 2 open-market sales ($470K) across all tracked filings.

Where can I see all of Smith Mark Douglas's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Smith Mark Douglas — SEC Form 4 Insider Trading Activity